hememalignancy.mc.duke.edu  
School of Medicine » Department of Medicine » Division of Cell Therapy
Conferences
Duke Debates | Tumor Board | Duke Debates Archive
Duke Debates - Controversies in the Management of Patients with Hematologic Malignancies
March 7th-8th, 2008
The Grove Park Inn, Asheville, NC

Each year, the Duke Hematologic Malignancy Program holds a national conference with experts from Duke and around the world coming together to debate the best new approaches to the care of patients with hematologic malignancies. Primary Oncologists, hematopathologists, nurse practitioners, physician's assistants, nurses, pharmacists and support staff all benefit from this unique format which encourages audience participation in these timely discussions. With the positive growth of last year, we are expanding with the addition of focused small group sessions in pain control and complementary medicine, hematopathology, and cancer biology!

Please call Mrs. Monica Roberson at 919-419-5506 to learn more.
 
Preliminary Schedule
 

Friday, March 7, 2008

 

 

                     Registration for Simultaneous Sessions

 

                     Continental Breakfast

 

 

 

Advanced Practice Nursing and Pharmacist Program: Diffuse Large B-Cell Lymphoma Case Based Discussion

 

 

                      Welcome                                                                      Jennifer Loftis, RN, MSN

 

 

                     Epidemiology, Pathophysiology and Staging                    Heather Brumbaugh, RN, MSN, ANP, AOCN

 

 

                      Standard Treatment and Expected Response                   Donna Adams, RN, BSN, OCN

 

 

                      Indications for Stem Cell Transplantation             Martha Lassiter, RN, MSN

 

           

 

                      Break

 

 

                   New Drugs for Hematologic Malignancies                        Ashley M. Engemann, Pharm.D., BCOP

 

 

10:15-10:45                  Oral Chemotherapy Agents: Improving

 

                                    Compliance and Managing Toxicity                                 Sally Y. Barbour, Pharm.D.,BCOP, CPP

 

 

                 Discovery Process for Decision Making                          Kristine Sullivan, EdD

 

 

                  Spirituality- What Does It All Mean?                                Jill Burleson, RN, ANP

 

 

 

 

Practical Hematopathology: Controversies and Pitfalls

 

 

                     Welcome                                                                      Patrick Buckley, MD, PhD

 

 

                     Applying Genomics to the Lymphoma Patient                   Sandeep Dave, MD, PhD

 

 

                     Overview of New Tests in Molecular                                 Mike Datto, MD, PhD

 

                                    Diagnostics, Flow Cytometry, and                                   Anand Lagoo, MD, PhD

 

                                    Cytogenetics                                                                 Barbara Goodman, PhD

 

 

                   Break

 

 

                 Hematopathology Workshop:                                          Drs. Buckley, Goodman, Lagoo & Datto

 

                                    Small Cell Lymphomas: Diagnostic pitfalls 

 

                                    Case-based Presentation Submitted by Cases

 

                                    Diagnostic Consultation and Discussion

 

                                    Community Pathologists and Course Faculty

 

                                                                                   

 

 

 

 

 

 

 

 

 

Duke Debates - Controversies in the Management of Patients with Hematologic Malignancies

 

March 7-8, 2008

 

The Grove Park Inn, Asheville, North Carolina

 

 

Friday, March 7, 2008

 

 

      Lunch

 

 

Main Session

 

     Welcome                                                                      Joseph Moore, MD

 

 

Chronic Disease and Chronic Issues                                                   Moderator:  David Rizzieri, MD

 

 

       Chronic Lymphocytic Leukemia (CLL) Induction:             William Weirda, MD, Ph.D.

 

How Hard to Push? (case-based discussion)                                                      

 

 

1:20-2:00          ASCO/NCCN Guidelines for Thromboprophylaxis             Tom Ortel, MD, PhD

 

                        in the Cancer Patient-   

 

 

          Today’s Best Therapy for Chronic Myelogenous              Joseph Moore, MD vs. Nelson Chao, MD, MBA

 

                        Leukemia (CML): When Induction Fails to Provide

 

                        a Cytogenetic Response 

 

 

         Break

 

 

Leukemia                                                                                             Moderator:  Joseph Moore, MD

 

 

         Emerging Therapies for Multiple Myeloma.                      William Richardson, MD vs. Cristina Gaspareto, MD

 

 

          Is there an Optimal Induction Therapy for MDS                Carlos DeCastro, MD

 

                        (Mylodysplastic Syndrome)?                  

 

 

         Tumor Board Case Presentations:                                   Drs. Moore, Chao, DeCastro & Rizzieri

 

                        Mylodysplastic Syndrome (MDS)                                   

 

                        Elderly                                                                         

 

                        Targeted Therapy Cases                                                                                                                                                *** Audience Participation Highly Encouraged****

 

 

      Wine and Cheese Reception

 

 

 

Saturday, March 8, 2008

 

 

Lymphoma                                                                                           Moderator:  Louis Diehl, MD

 

 

          Breakfast

 

 

         Erythropoietin biology in non-hematopoietic organs and cancer   Murat Arcasoy, MD PhD                                                     

 

 

         Approach to the Patient with High Risk IPI                       Ann Beaven, MD

 

(International Prognostic Index)             

 

                                                                                                           

 

       Lymphoma Tumor Board-                                               Drs, Diehl, Beaven, Rizzieri, & Weirda

 

                        Maintenance Therapy in Lymphoma                               

 

                        Radioimmunotherapy for Low Grade Lymphoma             

 

                        Initial treatment for Diffuse Large Cell Lymphoma

 

                        Measurement of Tumor Response

 

*** Audience Participation Highly Encouraged****          
Printer Friendly Page Send this Story to a Friend
DHTS Strategic Web Services DHTS STRATEGIC WEB SERVICES